MEI Pharma Files 8-K with Financials and Other Events
Ticker: LITS · Form: 8-K · Filed: Aug 5, 2025 · CIK: 1262104
| Field | Detail |
|---|---|
| Company | Mei Pharma, INC. (LITS) |
| Form Type | 8-K |
| Filed Date | Aug 5, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, financial-reporting, corporate-events
TL;DR
MEI Pharma dropped an 8-K on Aug 5th covering financials and other key updates.
AI Summary
MEI Pharma, Inc. filed an 8-K on August 5, 2025, reporting on various events. The filing includes information related to financial statements and exhibits, as well as other events and a Regulation FD Disclosure. The company, incorporated in Delaware, is based in San Diego, California.
Why It Matters
This 8-K filing provides an update on MEI Pharma's corporate activities and financial reporting, which is crucial for investors to assess the company's current status and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of corporate events and financial information, not indicating any immediate material adverse changes.
Key Players & Entities
- MEI Pharma, Inc. (company) — Registrant
- August 05, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- San Diego, California (location) — Principal Executive Offices
- 858 369-7100 (phone_number) — Registrant's Telephone Number
FAQ
What specific events are being reported in this 8-K filing?
The filing indicates it covers Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits.
When was the earliest event reported in this filing?
The earliest event reported was on August 05, 2025.
What is the principal business address of MEI Pharma, Inc.?
The principal executive offices are located at 9920 Pacific Heights Blvd., Suite 150, San Diego, California, 92121.
What is the Commission File Number for MEI Pharma, Inc.?
The Commission File Number is 001-41827.
What is the IRS Employer Identification Number for MEI Pharma, Inc.?
The IRS Employer Identification Number is 51-0407811.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on August 5, 2025 regarding MEI Pharma, Inc. (LITS).